Structural analysis, molecular modelling and preliminary competition bnding studies of AM-DAN as a NMDA Receptor PCP-Site Fluorescent Ligand
Loading...
Date
2019
Journal Title
Journal ISSN
Volume Title
Publisher
MDPI
Abstract
Excitotoxicity related to the dysfunction of the N-methyl-d-aspartate receptor (NMDAR)
has been indicated to play an integral role in the pathophysiology of multiple disease states, including
neurodegenerative disorders such as Parkinson’s disease. There is a notable gap in the market
for novel NMDAR antagonists, however current methods to analyse potential antagonists rely
on indirect measurements of calcium flux and hazardous radioligand binding assays. Recently, a
fluorescent NMDAR ligand, N-adamantan-1-yl-dimethylamino-1-naphthalenesulfonic acid, known
as AM-DAN was developed by our group. Additional studies on this ligand is necessary to evaluate
its potential as a biological tool in NMDAR research. Therefore, this study was aimed at conducting
structural analyses, fluorescence experiments, high-accuracy NMDAR molecular modelling and
NMDAR phencyclidine (PCP) site competition binding studies using AM-DAN. Results revealed that
AM-DAN has appropriate structural properties, significant fluorescent ability in various solvents and
is able to bind selectively and compete for the PCP-binding site of the NMDAR. Therefore, AM-DAN
holds promise as a novel fluorescent ligand to measure the affinity of prospective drugs binding at
the NMDAR PCP-site and may circumvent the use of radioligands.
Description
Keywords
Molecular modelling, Fluorescent ligand, Pharmacy, Fluorescent bioassay, Amantadine
Citation
Ndzibongwana, S.; Ngobese, S.; Sayed, A.; Shongwe, C.; White-Phillips, S.; Joubert, J. Structural Analysis, Molecular Modelling and Preliminary Competition Binding Studies of AM-DAN as a NMDA Receptor PCP-Site Fluorescent Ligand. Molecules 2019, 24, 4092. https://doi.org/10.3390/molecules24224092